Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population
Clinical trial NCT00150384 · COMPLETED
Trial details
- NCT number
- NCT00150384
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.